Thermalytix
Breast Cancer Screening
ApprovedActive
Key Facts
About Niramai
Niramai is a pioneering diagnostics company leveraging artificial intelligence and thermal imaging to revolutionize breast cancer screening. Its flagship Thermalytix platform offers a radiation-free, portable, and privacy-sensitive alternative to traditional mammography, with clinical validation supporting high accuracy across all ages and breast densities. With US FDA clearance for its SMILE-100 system, a growing global footprint, and strong backing from patents and clinical publications, Niramai is positioned to address critical gaps in early detection accessibility, particularly in low-resource and rural settings. The company represents a significant convergence of AI, medtech, and preventive healthcare.
View full company profileTherapeutic Areas
Other Breast Cancer Screening Drugs
| Drug | Company | Phase |
|---|---|---|
| BREASTEST plus™ | Bcal Diagnostics | Commercial |
| Auria | Namida Lab | Commercial |
| Non-Contrast Breast MRI Screening Research | Ikonopedia | Research |
| Electrical Mammogram | NovaScan | Pre-clinical |
| KBCT for Primary Screening | Koning | Research / Aspirational |
| Breast Cancer Screening AI | Vara | Commercial |
| PRISM Randomized Controlled Trial | ScreenPoint Medical | Trial |